Vocal Fold Paralysis in Paediatric Patients With Arnold-Chiari Malformations: A Systematic Review and Meta-Analysis

Jad Hosri1, Vanessa Helou2, Jonathan Abou Chaar1

  • 1Department of Otolaryngology-Head and Neck Surgery, American University of Beirut Medical Center, Beirut, Lebanon.

Insights

Age at vocal fold paralysis (VFP) onset is critical for pediatric patients with Arnold-Chiari malformations (ACM). Younger VFP onset is associated with poorer recovery and survival outcomes in these ACM patients.

Area of Science:

  • Neurology
  • Pediatric Medicine
  • Genetics

Background:

  • Arnold-Chiari malformations (ACM) are congenital conditions affecting the cerebellum and brainstem.
  • Vocal fold paralysis (VFP) is a significant complication in pediatric ACM patients, impacting airway and feeding.
  • Understanding risk factors for VFP outcomes in ACM is crucial for patient management.

Purpose of the Study:

  • To identify and analyze risk factors influencing vocal fold paralysis (VFP) outcomes in patients diagnosed with Arnold-Chiari malformations (ACM).
  • To determine the association between the age of VFP onset and patient recovery and survival rates within the ACM cohort.

Main Methods:

  • A systematic review adhering to the 2020 PRISMA checklist was performed.
  • Comprehensive literature searches were conducted across multiple databases for studies on ACM and VFP.
  • Meta-analysis, including Chi-squared tests and binary logistic regression, was employed to assess variable associations.

Main Results:

  • The review included 33 studies with 165 pediatric patients (mean age 15.31 months); Chiari type 2 was predominant (120 cases).
  • Bilateral VFP occurred in 103 patients; common treatments included ventriculoperitoneal shunt (65.45%) and posterior fossa decompression (52.12%).
  • A significant association was found between VFP onset age and recovery/survival rates in the overall and ACM II cohorts.

Conclusions:

  • Age at onset of vocal fold paralysis (VFP) is a critical prognostic factor in pediatric ACM patients.
  • Younger age at VFP onset correlates with incomplete symptom resolution and reduced survival rates.
  • Early identification of VFP and its timing are essential for optimizing outcomes in ACM.
Abstract

Related Concept Videos

Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
408
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
487
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
358
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
878